Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.105.10 CHF
Change Today -1.80 / -1.68%
Volume 31.8K
YPSN On Other Exchanges
Symbol
Exchange
YPSN is not on other exchanges.
As of 11:43 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for ypsomed holding ag-reg (YPSN)

Year over year, Ypsomed Holding AG has been able to grow revenues from SFr.276.3M CHF to SFr.306.6M CHF. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 74.47% to 72.00%. This was a driver that led to a bottom line growth from SFr.13.6M CHF to SFr.19.4M CHF.
View Income Statement In U.S. Dollar
Currency in
Millions of Swiss Francs
As of:Mar 31
2012
Reclassified
CHF
Mar 31
2013
CHF
Mar 31
2014
Restated
CHF
Mar 31
2015
CHF
4 Year
Trend
Revenues248.6244.6276.3306.6
TOTAL REVENUES248.6244.6276.3306.6
Cost of Goods Sold192.2187.5205.7220.8
GROSS PROFIT56.457.170.585.9
Selling General & Admin Expenses, Total53.354.155.460.2
Other Operating Expenses-1.9-1.8-0.4-1.3
OTHER OPERATING EXPENSES, TOTAL51.452.355.058.9
OPERATING INCOME4.94.715.526.9
Interest Expense-0.8-0.9-1.0-0.8
Interest and Investment Income0.00.00.00.0
NET INTEREST EXPENSE-0.7-0.9-1.0-0.8
Currency Exchange Gains (Loss)-1.1-0.2-0.6-2.4
Other Non-Operating Income (Expenses)1.40.40.00.2
EBT, EXCLUDING UNUSUAL ITEMS4.54.114.023.9
Gain (Loss) on Sale of Investments5.1-1.11.1-1.7
Gain (Loss) on Sale of Assets0.20.10.11.6
EBT, INCLUDING UNUSUAL ITEMS9.73.115.223.7
Income Tax Expense1.21.41.64.3
Earnings from Continuing Operations8.51.613.619.4
NET INCOME8.51.613.619.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS8.51.613.619.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS8.51.613.619.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YPSN:SW SFr.105.10 CHF -1.80

YPSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Antares Pharma Inc $1.79 USD +0.08
Bioject Medical Technologies Inc $0.05 USD -0.009
Terumo Corp ¥3,340 JPY +85.00
Unilife Corp $1.24 USD +0.10
West Pharmaceutical Services Inc $56.86 USD -0.23
View Industry Companies
 

Industry Analysis

YPSN

Industry Average

Valuation YPSN Industry Range
Price/Earnings 69.1x
Price/Sales 4.4x
Price/Book 5.6x
Price/Cash Flow 69.3x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YPSOMED HOLDING AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.